<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02491385</url>
  </required_header>
  <id_info>
    <org_study_id>2014-12-129</org_study_id>
    <nct_id>NCT02491385</nct_id>
  </id_info>
  <brief_title>Thoracic Epidural for Postoperative Ileus</brief_title>
  <official_title>Effect of Thoracic Epidural Analgesia on Bowel Function Recovery in Major Upper Abdominal Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators try to find whether thoracic epidural analgesia (TEA) shortens the first
      gas-out time compared to iv-PCA and promotes earlier discharge after major upper abdominal
      surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative ileus (POI) is a prolonged inhibition of coordinated bowel activity after
      surgery. Half of patients undergoing major abdominal surgery experience POI making it one of
      the limiting factors for early recovery.

      The pathogenesis of POI is multifactorial, and includes neurogenic, inflammatory and
      pharmacological mechanisms. Thoracic epidural analgesia (TEA) can induce sympathetic block,
      attenuate inflammatory reaction and limit use of systemic opioids. In addition, sympatholysis
      induced by TEA can improve microcirculation of bowels and parasympathetic activation can
      increase gastrointestinal motility.

      However, studies comparing TEA and iv-PCA on POI are rare in major upper abdominal surgeries.
      This study, therefore, compares TEA and iv-PCA in terms of bowel function recovery as a
      primary endpoint in major upper abdominal surgeries. Secondary endpoints are side effects and
      hospital stay.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>gas out time</measure>
    <time_frame>from operation to post operative 10 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>voiding time</measure>
    <time_frame>from operation to post operative 10 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>numeric rating scale for pain</measure>
    <time_frame>from operation to post operative 3 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Ileus</condition>
  <arm_group>
    <arm_group_label>TEA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>thoracic epidural analgesia group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iv-PCA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intravenous patient controlled analgesia group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>thoracic epidural analgesia</intervention_name>
    <description>In a sitting position, an 18-gauge Tuohy needle is introduced at T6-7 or T7-8 intervertebral space using a paramedian approach. An epidural catheter is advanced 5 cm beyond the tip of the needle and secured with a sterile dressing. For TEA regimen, hydromorphone (8 mcg/ml) was added to 0.15% ropivacaine. TEA setting was bolus/lock out time/basal, 3 ml/15 min/5 ml.</description>
    <arm_group_label>TEA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>iv-PCA</intervention_name>
    <description>iv-PCA setting was fentanyl 20 mcg/ml, bolus/lock out time/basal, 0.5 ml/15 min/0.5 ml.</description>
    <arm_group_label>iv-PCA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists' (ASA) physical statusⅠ-Ⅲ

        Exclusion Criteria:

          -  ASA status of Ⅳ, or more

          -  Body mass index 30 kg.m2-1 or more

          -  Severe renal, hepatic, or neurologic diseases

          -  Opioid or systemic analgesic preoperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyun Joo Ahn, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung medical center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2015</study_first_posted>
  <last_update_submitted>July 2, 2015</last_update_submitted>
  <last_update_submitted_qc>July 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>Hyun Joo Ahn</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Thoracic epidural analgesia</keyword>
  <keyword>bowel function recovery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ileus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

